The human papilloma virus (HPV) is the cause of a large number of pathological situations, both in men as in women. The most frequent is condylomata acuminata or genital warts and is the leading cause of cancer of the uterus, which is the second most prevalent type of cancer among women all over the world. Up to this point, 100 genotypes have been isolated out of which about 42 have been located in the genital area. There are two categories that have been grouped according to its association with cervical cancer: high risk or probable high risk and intermediate risk and low oncogenic risk. The persistence of infection with a specific genotype increases the risk of cervical cancer. The oncogenic risk is increased by the co-infection of different genotypes of HPV. PCR analysis through Array Micro is fully innovative, with high sensitivity and specificity which uses low-density micro-arrays to detect 35 genotypes of HPV which produces an automatic reading and interpretation of results. Genotyping allows the detection of these co-infections by determining how many types are present and the risk that each one involves. Genotyping is a tool for vaccine screening on women who have had sex; it allows us to monitor the effectiveness and duration of the vaccine by detecting and following up on other genotypes for which the vaccine is not effective. The test can be done with Liquid cytology (Thin Prep), Swab (swab) and tissue on paraffin samples.